New Call for Abstracts and Registration [International Conference on AIDS (8th: 1992: Amsterdam, Netherlands)]

902 lymphotoxin
903 lysozyme
904 macrophages
905 magnetic resonance imaging
(MRI)
906 malaria
907 matrix protein
908 mathematical model, SEE model
909 measles
910 media
911 megestrol
912 melanin
913 membrane protein inhibitors
914 meningoencephalitis SEE also
specific pathogens
915 merocyanine (MC 540)
916 metabolism
917 methadone, SEE IVDU
918 methisoprinol
919 MHC antigens
920 microsporidia
921 migration
922 military
923 minorities
924 MM-i1
925 MoMLV
926 model, animal, SEE animal
models
927 model, computer
928 model, mathematical
929 monensin
930 monoclonal antibodies, env
931 monoclonal antibodies, gag
932 monoclonal antibodies, HIV-2
933 monoclonal antibodies, human
934 monoclonal antibodies,
neutralizing
935 monoclonal antibodies, pol
936 monoclonal antibodies, other
937 monocytes
938 morphine
939 mortality
940 MTP-PE
941 multiple sclerosis
942 MuLV
943 murine AIDS
944 mutation
945 mycobacteria, tuberculosis
946 mycobacteria, M. avium
complex
947 mycobacteria, non-tuberculosis,
others
948 mycoplasma infection
949 myelopathy
950 myocarditis
951 myopathy
952 N-glycosylation
953 naltrexone
954 naphtylaminesulphonic acid
955 national AIDS program, SEE
public policy

956 national policy, SEE public
policy

957
958

natural cytotoxicity, NK
natural cytotoxicity, LAK

959 natural cytotoxicity, other
960 natural history, SEE progression
961 neonates, SEE children
962 needle-syringe exchange, SEE
IVDU
963 needle sticks, SEE health care
personnel
964 neoplasia, SEE cancers
965 neopterin
966 nervous system, peripheral
967 neuropsychology
968 neurology, SEE central nervous
system
969 neurotropin
970 neutropenia
971 neutrophils
972 new infectious agents
973 nitrite inhalants
974 nitrophenol derivatives
975 Nocardia asteroides
976 non-governmental organizations
(NGO)
977 non-governmental organizations, SEE also communitybased organizations
978 nonoxinol-9
979 nucleocapsid protein
980 nucleoside analogues, SEE
specific compounds
981 nucleoside dimers
982 nurses, SEE health care
personnel
983 nutrition
984 occupational therapy
985 oligoclonal immunoglobulins
986 oligosaccharides
987 oncogenes
988 opportunistic infections
989 opportunistic infections, SEE
also specific organisms
990 opsonization
991 oral flora
992 oral manifestations
993 oral manifestations, hairy
leukoplakia
994 oral sex, SEE transmission
995 oral sex, SEE also sexual
behavior
996 otorhinolaryngologyI
997 out of hospital care
998 outpatient care
999 oxidant
1000 oximetry
1001 ozone
1002 p24 antigen/antibody
1003 palliative care
1004 panax ginseng
1005 pancreas
1006 papaverine (RS 47)
1007 papillomavirus, bovine

1008 papillomavirus, human

1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
1037
1038

paracoccioidomycosis
parallel track
paraproteins
parasites
parenteral nutrition
parents, SEE family
parotitis
partner notification
passive immunotherapy
pathogenesis
pediatric, SEE children
peer support, SEE group support
pelvic inflammatory disease
penicillin, SEE benzathine
penicillin
Penicillium marneffei
pentamidine
pentamidine, inhaled
pentosan-polysulfate
peptide T
peptides, native
peptides, recombinant
peptides, synthetic
peptides, other
perception of risk, SEE risk
peripheral blood lymphocytes
(PBL)
pets
phagocytes
pharmacokinetics
phenytoin
phorbol ester (TPA)

1062 polio vaccine
hyperimmunization
1063 politics
1064 polyantigenic immunoregulator
(PAI)
1065 polymerase chain reaction
(PCR)
1066 poverty
1067 pregnancy
1068 prevalence, general
1069 prevalence, progression
1070 prevalence, SEE bisexuals
1071 prevalence, SEE children
1072 prevalence, SEE gay men
1073 prevalence, SEE general
population
1074 prevalence, SEE geographical
regions
1075 prevalence, SEE hemophilia
1076 prevalence, SEE heterosexuals
1077 prevalence, SEE IVDU
1078 prevalence, methodology
1079 prevalence, SEE pregnancy
1080 prevalence, SEE prisoners
1081 prevalence, SEE prostitutes
1082 prevalence, other
1083 prevalence, SEE also serologic
tests, breastfeeding, transmission, prevention
1084 prevention, SEE children
1085 prevention, evaluation
1086 prevention, SEE gay men
1087 prevention, SEE hemophilia
1088 prevention, SEE heterosexuals
1089 prevention, SEE IVDU
1090 prevention, SEE prisoners
1091 prevention, SEE prostitutes
1092 prevention, other
1093 primaquine
1094 prisoners, prevalence
1095 prisoners, prevention
1096 prisoners, other
1097 privacy
1098 probenicid
1099 productivity
1100 prognosis, SEE beta-2 -microglobulin
1101 prognosis, CD4 lymphocytes
1102 prognosis, SEE children
1103 prognosis, SEE gay men
1104 prognosis, SEE hemophilia
1105 prognosis, SEE heterosexuals
1106 prognosis, SEE p24 antigen
1107 prognosis, SEE IVDU
1108 prognosis, laboratory markers,
SEE neopterin
1109 prognosis, other
1110 program evaluation
1111 program, national
1112 progression, anergy
1113 progression, anti-HIV antibodies

1114 progression, asymptomatic
stages

1039 phosphatidyl choline
1040 phylogenetic
1041 physical exercise
1042 physicians, SEE health care
personnel
1043 pine cone extract
1044 piritrexin
1045 placebo controls
1046 placenta
1047 plasmacytoma
1048 plasmapheresis
1049 PMEA
1050 PML
1051 pneumococcal infections
1052 Pneumocystis carinii pneumonia
(PCP)
1053 Pneumocystis carinii pneumonia
(PCP), diagnosis
1054 Pneumocystis carinii pneumonia
(PCP), prognosis
1055 Pneumocystis carinii pneumonia
(PCP), prophylaxis
1056 Pneumocystis carinii pneumonia
(PCP), treatment
1057 Pneumocystis carinii pneumonia
(PCP), other
1058 pneumonia, SEE individual
organisms
1059 pneumonitis
1060 pneumothorax
1061 pokeweed antiviral protein

xxiv